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ABSTRACT
A clinical study was undertaken on bovine mastitis in the Kashmir valley to study the relationship between 
Phagocytic activity (PA) and the phagocytic index (PI) of milk neutrophils (PMN’s) and bovine mastitis. The PA 
and PI of milk PMN’s were assessed in mastitic animals and compared with normal, healthy, lactating animals. 
A significant decrease was found in the values of the PA and PI of milk neutrophils in clinical cases of mastitis as 
compared to the healthy control group. The utility of anti-oxidants in clinical management of mastitis was measured 
through the response to treatment with trace minerals such as Cu, Zn, Mn and Se in addition to conventional antibiotic 
therapy. Two groups of mastitic animals received two therapeutic regimens. Group I animals received antibiotics 
(Enrofloxacin 6.6 mg/kg BID for 5 days) and a self-formulated trace mineral anti-oxidant mixture at therapeutic doses 
for 7 days, while Group II animals only received the antibiotic (at the same dose rate and frequency). Therapeutic 
regimen I proved more efficacious than the therapeutic regimen II in the treatment of clinical mastitis, as evidenced by 
higher recovery rates, a lower number of mean days required for recovery, and higher PA and PI of the milk PMN’s 
on day 10 post treatment. For prophylactic studies, 24 healthy lactating cows were divided into two groups of 12 
animals each. One group was supplemented with a self-formulated trace mineral anti-oxidant mixture at prophylactic 
doses for 30 days, which resulted in a significant improvement in udder health status in terms of the SCC, PA and 
PI of milk PMN’s. Supplementation with the antioxidant formulation played a significant role in early recovery and 
prophylaxis of bovine mastitis. Assessment of PA and PI of milk PMN’s could be utilised as an effective tool for 
diagnosing susceptibility to the occurrence of mastitis, as well as monitoring the therapeutic efficacy of different 
treatment regimes. 
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the bone marrow (KIMURA et al., 1999). Clearly, 
a significant component of the dietary energy and 
protein consumption for maintenance is spent on 
replenishment of immune cells. So, supplementing 
trace minerals and vitamins in greater quantity in 
and around parturition reduces both the duration 
and the severity of udder affections, and enhances 
udder immunity (WEISS, 2002). So the best 
way to treat mastitis is to give mastitic cows 
the best possible hygienic conditions and an 
appropriate diet. It has been proved that dietary 
supplementation with high levels of Vitamin E 
during the periparturient period substantially 
benefits udder health (BOUWSTRA et al., 2010) 
and enhances the chemotactic responsiveness of 
blood neutrophils (EICHER et al., 1994). Enhanced 
phagocytic activity and phagocytic index have 
also been reported in milk PMN cells in mastitic 
buffaloes treated with enrofloxacin, vitamin E and 
selenium (MUKHERJEE, 2008). Supplementation 
with antioxidants may prove an effective tool for 
protecting mammary tissue against PMN-induced 
oxidative stress during bovine mastitis, and in 
addition antioxidant supplementation may also 
help in preventing mastitis by strengthening the 
mammary defense system and improving immunity. 
So the present study was undertaken to study the 
effect of supplementation of anti-oxidant trace 
minerals on the clinical recovery, prophylaxis, and 
phagocytic activity and phagocytic index of milk 
PMN’s in bovine mastitis. The role of the PA and 
PI of milk PMN’s as diagnostic and prophylactic 
markers of bovine mastitis was also evaluated.
Materials and methods
The study was undertaken on clinical cases 
of bovine mastitis presented for treatment to the 
Teaching Veterinary Clinical Complex, F.V.Sc 
& A.H, SKUAST-K and local animal husbandry 
dispensaries in the areas of Ganderbal, Manasbal, 
Shuhama, Gulab Bagh and Shalimar during the 
course of study. 
A total of 36 multiparous cows in the 4-8 years 
age group with body condition score (BCS) 3.0, 
were included for the study. Twenty-four cows 
among them had clinical mastitis, 12 apparently 
healthy lactating animals served as a control group, 
introduction
Mastitis is a difficult problem to comprehend 
because of its multifactorial infectious nature. Its 
incidence depends on the microorganisms involved, 
the surrounding environment and the defense 
mechanisms in the udder tissues and blood. The 
mammary gland is protected by a variety of defense 
mechanisms, such as non-phagocytic and phagocytic 
defences (ATABAI et al., 2007: MEHRZAD et al., 
2010). The phagocytic defence consists mainly of 
phagocytic cells in the mammary gland and those 
recruited in response to inflammatory reactions 
(PMNs/Neutrophils). Neutrophils form the integral 
part of mammary innate defense system during 
foreign intrusion of microbes as an early response of 
the host body (BORREGAARD, 2010). The ability 
of neutrophils to phagocytose foreign particles is 
important for protection of the mammary gland, 
and in vitro analysis of neutrophil function provides 
a very effective tool for the study of natural 
mastitis resistance (AL HUSSSEIN et al., 2015). 
It has been reported that the main reason for the 
increased susceptibility in dairy animals to mastitis 
is immune-suppression (MALLARD et al., 1998). 
Successful intramammary defence is dependent on 
an increase in PMN arriving at the site of infection 
and a high rate of phagocytosis (PAAPE et al., 
2003). Any condition that depresses PMN functions 
adversely affects the udder’s resistance to invasive 
infections (MEHRZAD et al., 2009). The increased 
incidence of severe mastitis during early lactation 
correlates with decreased blood and milk PMN 
(MEHRZAD et al., 2010), further emphasizing 
the pivotal role of PMN in the defence against 
intramammary pathogens. Phagocytic activity (PA) 
is the percentage of neutrophils that phagocytosed 
the target organisms in an in vitro condition, and the 
phagocytic index (PI) is calculated as the average 
number of target microorganism(s) phagocytosed 
per phagocyte. Although the phagocytic ability of 
the milk neutrophils in the mammary gland is lower 
than in other tissues, it still remains the most critical 
defense once the teat end barrier is breached. The 
circulating half-life of neutrophils is about 6 hours, 
so the cow replaces half of those cells every 6 hours 
from its bone marrow stores, and the circulating pool 
is largely dependent on the proliferative capacity of 
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and no experimental case was included. The cases 
of clinical mastitis were diagnosed on the basis 
of clinical examination, case history and clinical 
findings. The severity of the cases was assessed on 
the basis of CMT score and SCC of milk samples. 
Cases with a CMT score of 2 or 3, with somatic 
cell counts higher than 4×105 /mL of milk were 
considered positive for mastitis. 
For performing therapeutic trials, the mastitic 
animals were diagnosed by clinical presentation, 
CMT score and SCC, and were further divided into 
two groups of twelve animals each. The animals in 
group I were given a self-formulated anti-oxidant 
trace mineral mixture at therapeutic doses, as 
recommended by NRC, 2001, whose formulation 
is given in Appendix 1. All four ingredients were 
mixed together, making a total weight of about 
5.005 g, and stored in air-tight, zip lock, polyethene 
pouches. A total of 7 pouches were given to 
individual animal owners so they could provide 
the contents of one pouch to the animals once daily 
for 7 days. Group II animals were not given any 
anti-oxidant trace mineral mixture. Both the groups 
of animals were given the antibiotic enrofloxacin 
at the dose rate of 6.6mg/kg i/m per animal, twice 
daily for 5 days. The choice of the antibiotic was 
based on an antibiotic sensitivity test of the milk, 
which was performed in each case. Animals found 
to be insensitive to enrofloxacin were excluded 
from the study. The therapeutic trial design for the 
cows with clinical mastitis is provided in Table 1.
For the prophylactic study, 24 recently 
parturiated, lactating animals maintained at the 
Mountain Livestock Research Institute (MLRI), 
SKUAST-K, Manasbal, under similar managemental 
conditions, but with susceptibility to occurrence of 
mastitis (as evidenced by precedence to occurrence 
of mastitis in previous lactations) were selected. 
One group of animals (Group I) comprised of 12 
animals, received a self-formulated anti-oxidant 
trace mineral mixture for a period of thirty days, 
while Group II also comprised of 12 animals did 
not receive any anti-oxidants. The anti-oxidant 
trace minerals were given at prophylactic doses as 
recommended by NRC, 2001. The composition of 
the anti-oxidant trace mineral mixture is given in 
Appendix I. The total dose per animal was 1.402 
grams. Three hundred and sixty pouches were 
made, and one pouch per animal per day was given 
to Group I animals for 30 days.
The efficacy of the prophylactic treatment was 
evaluated by registering the occurrence of mastitis 
during the course of the therapy and one month after 
therapy. The udder health status of both the groups 
of animals was assessed on the basis of an estimation 
of the SCC of the milk, phagocytic activity and the 
phagocytic index of the milk PMN’s day 0, day 
15 and day 30 of treatment, and fifteen days after 
the end of the treatment. Both groups of animals 
were monitored for the occurrence of mastitis for 
a period of one month after the end of the therapy.
Table 1. Therapeutic trial design for cows with clinical mastitis
Group
No. of animals 





Inj. Enrofloxacin 6.6 mg/kg I/M BID 5 days
Anti-oxidant trace 




12 Inj. Enrofloxacin 6.6 mg/kg I/M BID 5 days
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The phagocytic activity of the milk PMN’s was 
estimated from the milk of healthy lactating cows 
as well as from clinical cases of mastitis on day 0, 
day 5 and day 10 of treatment and for prophylactic 
studies on day 0, day 15 and day 30 of treatment. The 
in vitro phagocytosis activity of milk neutrophils 
(PMN) was determined on Staphylococcus aureus. 
The procedure was performed in the following 
manner:
Isolation of milk PMN’s. A total of 50 mL of milk 
was passed through cheese cloth and then poured 
into 50 mL conical tubes and centrifuged in a cooling 
centrifuge at 1200g or 2942 rpm (approximately 
3000) at 4 °C. The fat was removed and the skim 
milk was poured off and discarded. The cell pellet 
was washed twice in cold Dulbecco’s PBS and 
centrifuged at 300g for 10 minutes and 200g for 15 
minutes at 4 °C and resuspended in Dulbecco’s PBS 
containing 0.5mg/mL gelatin. In a 15 mL falcon, 
3mL of Histopaque 1119 (Sigma Aldrich, USA) was 
taken, over which 3 mL of Histopaque 1077 (Sigma 
Aldrich, USA) was layered slowly so as to form a 
ring at the junction of the two histopaques. Three 
mL of cell suspension was layered slowly over the 
Histopaque 1077. The tube was gently placed into 
the centrifuge and centrifugation was carried out at 
2000 g at 4 °C for 30 minutes. The cell pellet formed 
at the interface between the Histopaque 1119 and 
1077 was taken as the milk PMN’s. The collected 
cells were washed twice with PBS and resuspended 
in RPMI medium containing 10% fetal calf serum 
for further analysis, and they served as the source 
of milk PMN’s. The viability of milk PMN’s was 
checked by the trypan blue exclusion technique, 
and the final cell concentration was adjusted to 
1×106 cells/ml.
Viable cell count of milk leukocytes. Before 
the cells had the chance to settle, 0.5 mL of cell 
suspension was transferred into an Eppendorf 
tube.100 µL of cells were transferred into a new 
Eppendorf tube, 400 µL of 0.4% trypan blue 
was added and gently mixed. One hundred µL 
of trypan blue treated cells were loaded onto a 
haemocytometer. The viable (unstained) cells 
were counted in all the four sets of 16 corners 
(WBC counting chambers).Viable cell count was 
expressed as: 
Viable cell count = Average count in 4 squares × 
Dilution factor ×104
% Viability = All live and dead cells were added to 
obtain the total cell count. The live cell count 
was divided by the total cell count to calculate 
the viability percentage.
Dilution factor = 5
Viability of all the samples was more than 90%.
Adjustment of cell numbers. The concentration in 
the cell suspension was adjusted to 2.5×106 cells/mL.
X mL of RPMI added = 
No. of viable cells per mL
2.5×106
(e.g., if the viable cell count was 5×106, X-1 
mL of RPMI i.e. 2 -1 = 1 mL of RPMI was added 
to PMN suspension to reach a concentration of 
2.5×106 cells/mL).
Phagocytic activity and phagocytic index. 
Bacterial concentration of 18hour culture of pure 
Staphylococcus aureus (MTCC, Chandigarh) was 
adjusted to 2 ×108  cfu/mL by checking optical density 
(OD) at 540 nm under a UV spectrophotometer (OD 
was adjusted to 0.6 with PBS). For phagocytosis 
assay, 0.1 mL of the bacterial suspension was 
opsonised with 0.1 mL of pooled bovine serum in 
an incubator at 37 °C for 1 hour, in a tissue culture 
plate. Then 0.8 mL of PMN suspension was added 
and incubated at 37 °C for 30 minutes to maintain 
the PMN’s and bacteria in a ratio of 1:10. Smears 
were prepared and stained with Leishman stain. 
The slides were then examined under a high power 
microscope at ×1000 magnification. 
PA (phagocytosis percentage) was estimated as 
the percentage of cells that took part in phagocytosis 
Phagocytic activity = 
No. of PMN that 
engulfed bacteria × 100
No. of PMN counted
Phagocytic index (PI) was estimated as the mean 
of the total bacteria counted phagocytosed per 
neutrophil.
Phagocytic index = 
Total bacteria in N neutrophil
N
There was 25 neutrophils counted 25, so here N = 25.
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The result of PA was reported as the percentage 
(%) of phagocytosing neutrophils counting 100 
PMN cells in different microscope fields, and the 
result of PI was reported as the average number of 
bacteria per neutrophil.
Statistical analysis. The data was analysed 
using statistical tools (SPSS version 20). ANOVA 
followed by Duncan’s multiple range test were 
used for multiple comparisons. The paired ‘t’ test 
was used for pre- and post-treatment comparisons 
within each treatment group. Repeated measure 
ANOVA was used for multiple pre- and post-
treatmentcomparisons. Statistical differences were 
determined at the level of 5% significance. 
Results 
Phagocytic activity and the phagocytic index of 
milk neutrophils or PMN’s. The phagocytic activity 
(PA) and phagocytic index (PI) of milk neutrophils 
or PMN’s in the healthy control group and in 
animals with clinical mastitis (mastitic group) is 
presented in Table 2. The effect of the different 
therapeutic regimens (I & II) on the phagocytic 
activity and phagocytic index of milk neutrophils 
in the two groups of mastitic animals (Group I and 
Group II) is presented in Table 3. The mean values 
for the phagocytic activity of milk neutrophils (%) 
in the healthy control group of animals (35.42 ± 
1.27) was significantly higher (P<0.05) than that of 
the mastitic group values (18.30 ± 0.46), as shown 
in Table 2. The mean values for the phagocytic 
activity of neutrophils (%) in group I animals with 
clinical mastitis were 18.13 ± 0.58, 23.07 ± 0.78 and 
33.47 ± 1.08 on day 0, day 5 and day 10 of receiving 
therapeutic regimen I, respectively (Table 3). 
The mean values of the phagocytic activity 
of milk neutrophils (%) on days 0, 5 and 10 of 
treatment within group I mastitic animals differed 
significantly from each other (P<0.05). In group 
II animals with clinical mastitis, the mean values 
of the phagocytic activity of milk neutrophils (%) 
on days 0, 5 and 10 of treatment with therapeutic 
regimen II were 18.5 ± 0.76, 24 ± 0.95 and 28.25 
± 0.83, respectively, and also differed significantly 
(P<0.05) from each other (Table 3). The mean 
value of PI in the healthy control group was 6.82 
± 0.16, while in mastitic group the mean value was 
3.64 ± 0.10 (Table 2). The difference in the mean 
values of PI between the healthy control group 
and the mastitic group was statistically significant 
(P<0.05). The mean values for the PI of neutrophils 
in group I animals with clinical mastitis were 3.65 
± 0.14, 5.33 ± 0.14 and 6.26 ± 0.07 on days 0, day 5 
and day 10 of treatment, respectively, and the mean 
values of the phagocytic index of neutrophils on 
days 0, 5 and 10 of treatment within this group of 
mastitic animals differed significantly (P<0.05%) 
from each other (Table 3). In group II animals with 
clinical mastitis the mean values were 3.62 ± 0.16, 
4.86 ± 0.17 and 5.79 ± 0.20 on day 0, day 5 and day 
10 of treatment, respectively, and the mean values 
of the phagocytic index of neutrophils on days 0, 
5 and 10 within this group of animals also differed 
significantly (P<0.05%) from each other (Table 3).
Recovery of animals. In group I animals, ten 
animals recovered within a mean 4 ± 0.5 days, as 
evidenced by clinical recovery (CMT negative), 
and the return of milk SCC and milk chemistry 
parameters to normal. 
Table 2. Comparison of Phagocytic activity (PA) and Phagocytic Index (PI) between healthy lactating  






Phagocytic Activity (%) 35.42 ± 1.27a 18.30 ± 0.46b
Phagocytic Index (average No. of bacteria phagocytosed 
per phagocyte) 6.82 ± 0.16
a 3.64 ± 0.10b
Values within a row with a superscript (a,b) with at least one common letter do not differ significantly at the level of 5% (P<0.05) 
from each other
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Table 3. Effect of treatment on Phagocytic Activity (PA) and Phagocytic Index (PI) in animals with clinical mastitis
Parameters Days of treatment
Group I (Antibiotic +  
Antioxidant trace minerals) Group II (Antibiotic only)
Phagocytic Activity 
(%)
Day 0 18.13 ± 0.58a 18.50 ± 0.77a
Day 5 23.07 ± 0.78b 24.00 ± 0.96b
Day 10 33.47 ± 1.08c 28.25 ± 0.83c
Phagocytic Index 
(Average No. of 
bacteria phagocytosed 
per phagocyte)
Day 0 3.65 ± 0.14a 3.62 ± 0.16a
Day 5 5.33 ± 0.14b 4.86 ± 0.17b
Day 10 6.26 ± 0.07c 5.79 ± 0.20c
Values within a column having superscript (a,b,c) with at least one common letter do not differ significantly at the level of 5% 
(P<0.05) from each other.
Table 4. Therapeutic efficacy of treatment regimes in animals with clinical mastitis
Group I Group II
Animals treated 12 12
Animals recovered 10 8
% Recovery 83.33% 66.66%
Recovery time (Days ± S.E) 4 ± 0.5 4.5 ± 0.8
Table 5. Impact of prophylactic anti-oxidant trace mineral therapy on udder health status of healthy lactating animals 
during treatment 
Parameters Days of treatment





Day 0 2.81 ± 0.07a1 2.81 ± 0.06a1
Day 15 2.65 ± 0.06a1 2.77 ± 0.06a1,2
Day 30 2.48 ± 0.03a2 2.97 ± 0.07b2
Phagocytic Activity (%)
Day 0 28.13 ± 0.58a1 28.50 ± 0.77a1
Day 15 31.07 ± 0.78a2 24.00 ± 0.96b2
Day 30 35.47 ± 1.08a3 28.25 ± 0.83b1,3
Phagocytic Index (Average No. of 
bacteria phagocytosed per phagocyte)
Day 0 3.65 ± 0.14a1 3.62 ± 0.16a1
Day 15 5.83 ± 0.14a2 4.06 ± 0.17b2
Day 30 6.96 ± 0.07a3 4.79 ± 0.20b2
Values within a row with a superscript (a,b) with at least one common letter do not differ significantly at the level of 5% (P<0.05) 
from each other. Values within a column with a (1,2,3) with at least one common number do not differ significantly at the level of 
5% (P<0.05) from each other.
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The percentage recovery was 83.33%. Group II 
animals were not given any mineral mixture. In this 
group of animals, 12 animals were treated, of which 
8 animals recovered completely within a mean 4.5 
± 0.8 days, as evidenced by clinical recovery (CMT 
negative) and the return of milk SCC and milk 
biochemical parameters to normal. The percentage 
recovery was 66.66%.
Prophylactic studies. The udder health status 
of both groups of animals was monitored through 
estimation of the somatic cell count and phagocytic 
activity, and the phagocytic index of neutrophils on 
days 0,15 and 30 during the course of treatment, 
as well as 15 days after the end of the treatment 
(Tables 5 and 6). The animals were monitored for 15 
more days, i.e. for a total period of one month after 
stopping the treatment, for occurrence of mastitis. 
Milk SCC was lower and the phagocytic activity 
of the milk PMN’s was significantly higher in the 
group I animals as compared to group II animals, as 
shown in Tables 5 and 6. Clinical mastitis was not 
observed in any of the animals in the two groups 
of animals, either during the course of treatment or 
one month after the study.
Table 6. Impact of prophylactic anti-oxidant trace mineral therapy on the udder health status of healthy lactating 
animals 15 days after stopping the therapy
Parameter Group I (With anti-oxidants) Group II (Without anti-oxidants)
SCC (×105/mL) 2.72 ± 0.09a 3.07 ± 0.06b
Phagocytic Activity (%) 38.40 ± 1.25a 29.90 ± 0.72b
Phagocytic Index(Average No. of 
bacteria phagocytosed per phagocyte) 7.26 ± 0.09
a 5.57 ± 0.19b
Values within a row with a superscript (a,b) with at least one common letter do not differ significantly at the level of 5% (P<0.05) 
from each other.
APPENDIX -I: Therapeutic dose of mineral mixture:
Copper sulphate:   1 gm.
Zinc sulphate:  2 gm.
Manganese sulphate: 2 gm
Selenium:  5 mg
Total Dose:  5.005g/animal/day for 7 days 
Appendix -II: Prophylactic dose of mineral mixture:
Copper sulphate : 500 mg 
Zinc sulphate : 500 mg
Manganese sulphate: 400 mg 
Selenium  : 2 mg
Total Dose : 1.042 g/animal/day for 30 days 
Fig. 1.Phagocytic activity of milk PMN’s Fig. 2. Phagocytic index of milk PMN’s
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discussion
Phagocytic activity and phagocytic index of milk 
neutrophils or PMN’s. Our findings of decreased 
phagocytic activity and lower phagocytic index in 
clinical mastitis are in agreement with the findings 
of AL-HUSSEIN et al. (2015), who also reported 
a significant decrease in phagocytic activity of 
milk PMN’s in cows with clinical and sub-clinical 
mastitis. Our findings are also in agreement with 
DE UK and MUKHERJEE (2013), who also found 
that the PA of milk leukocytes was lower in mastitic 
cows, whereas, a significant enhancement in PA 
was recorded in post-treated cows. PICCININI 
et al. (1999) also reported depressed milk PMN 
phagocytic activity associated with intramammary 
infection by S. aureus. 
Recovery of animals. Our findings of increased 
recovery in group I animals are supported by 
the fact that dairy cows supplemented with a 
combination of anti-oxidant trace elements (Se, Cu, 
Zn and Mn) in therapeutic regimen I vs. therapeutic 
regimen II showed better recovery rates (83.33% vs 
66.66%), a shorter recovery time (4 ± 0.5 days vs. 
4.5 ± 0.8 days) with higher phagocytic activity and 
phagocytic index of the milk PMN’s. Our findings 
of increased recovery rates through the use of anti-
oxidant trace mineral supplementation is supported 
by the findings of MACHADO et al. (2013).YANG 
and LI (2015) also reported that supplementation of 
mastitic dairy cows with antioxidant vitamins such 
as vitamin A, C, E and β-carotene, and antioxidant 
minerals such as selenium, zinc and copper was 
very important to help the animals recover early.
Prophylactic studies. The udder health status 
of group I animals was found to be better than 
group II as evidenced by a significant increase in 
phagocytic activity and the phagocytic index of 
their milk PMN’s, and the significant decrease in 
milk SCC count during the course of treatment and 
15 days after the end of treatment (Tables 5 and 6), 
indicating the increased capability of the udders 
to defend themselves against the attack of the 
pathogenic microorganisms responsible for causing 
mastitis, and hence the decreased susceptibility 
to the occurrence of mastitis in this group as 
compared to the control group. Our findings are 
in agreement with MACHADO et al. (2013) who 
reported that dairy cows supplemented with a 
combination of different trace elements (Se, Cu, 
Zn and Mn) showed lower SCC levels (decreased 
incidence of mastitis) in comparison to the control 
cows. SORDILLO and MAVANGIRA (2014) also 
advocated controlling mastitis through appropriate 
antioxidant supplementation in the form of trace 
mineral supplementation that could potentially 
boost the animals’ health status and performance.
Conclusion
Since the present study revealed significantly 
lower PA and PI of milk PMN’s in clinical mastitis, 
which subsequently increased with supplementation 
of an antioxidant mineral formulation,estimation of 
the PA and PI of milk PMN’s may prove to be an 
effective biomarker for detecting susceptibility to 
the occurrence of bovine mastitis, and monitoring 
the therapeutic efficacy of treatment regimes. Anti-
oxidant trace minerals such as Cu, Zn, Mn and Se 
significantly increase the PA and PI of milk PMN’s, 
and thereby aid early recovery from bovine mastitis 
and play a significant role in prophylaxis of mastitis 
in lactating animals. This study strongly supports 
the hypothesis that boosting the PA and PI of milk 
PMN’s through supplementation with an anti-
oxidant mineral mixture could prove an effective 
strategy to prevent and reduce the severity of 
bovine mastitis.
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Sažetak
Kliničko istraživanje mastitisa goveda u dolini Kashmir provedeno je kako bi se procijenila povezanost fagocitne 
aktivnosti (PA) i fagocitnih indeksa (PI) neutrofila u mlijeku (PMN’s) i mastitisa goveda. PA i PI neutrofila u mlijeku 
analizirani su u životinja s mastitisom i uspoređeni sa zdravim životinjama u laktaciji. Pronađeno je znakovito smanjenje 
PA i PI neutrofila u mlijeku u slučajevima kliničkog mastitisa u usporedbi s kontrolnom, zdravom skupinom. Korisnost 
Vet. arhiv 91 (3), 227-236, 2021236
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antioksidansa u slučajevima kliničkog mastitisa mjerena je putem odgovora na liječenje mineralima u tragovima kao 
što su Cu, Zn, Mn i Se, koji su dodani konvencionalnoj antibiotskoj terapiji. Dvije skupine životinja s mastitisom 
imale su dva terapijska programa. Skupina 1 primala je antibiotik (enrofloksacin 6,6 mg/kg, 2 puta dnevno, tijekom 5 
dana) i vlastito pripremljenu mješavinu antioksidantnih minerala u tragovima u terapijskoj dozi tijekom 7 dana, dok je 
skupina 2 dobivala samo antibiotike (u istoj dozi i intervalu). Terapijski program u skupini 1 pokazao se učinkovitijim 
od onoga u skupini 2 u liječenju kliničkog mastitisa, što dokazuju veće stope oporavka, manji prosječan broj dana 
potreban za oporavak te povećane vrijednosti PA i PI polimorfonuklearnih stanica mlijeka deseti dan poslije tretmana. 
Za istraživanje profilakse 24 zdrave krave u laktaciji podijeljene su u dvije skupine sa po 12 životinja. Jedna je skupina 
dobivala vlastito pripremljenu mješavinu antioksidantnih minerala u tragovima u profilaktičkoj dozi tijekom 30 dana. 
To je rezultiralo znakovitim poboljšanjem zdravlja vimena što se vidjelo po vrijednostima SCC, PA i PI neutrofila u 
mlijeku. Dodatak antioksidantne formulacije znakovito je utjecao na rani oporavak i profilaksu mastitisa u goveda. 
Procjena PA i PI polimorfonuklearnih stanica mlijeka mogla bi biti učinkovit alat pri dijagnostici sumnje na mastitis 
kao i praćenju učinkovitosti različitih terapijskih program.
ključne riječi: mastitis goveda; polimorfonuklearne stanice mlijeka; fagocitna aktivnost; fagocitni indeksi; 
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